Schedule 13D ownership disclosure
PRANA BIOTECHNOLOGY LTD SHS (A
Security class unavailable · CUSIP: Q7739U108
Event date: 2020-07-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 269,905,533
- Percent of class
- 24.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-081192
- Form type
- SC 13D
- Filer
- ALTERITY THERAPEUTICS LTD
- CIK
- CIK 1131343
- Filed
- Jul 06, 2020
- Reporting period
- Jul 02, 2020
- Description
- Schedule 13D beneficial ownership